Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cravihenz Tablet

Prescription Icon
Prescription Required

Marketer

Biokindle Lifesciences Pvt Ltd

Salt Composition

Megestrol (160mg)

Overview Cravihenz Tablet

Palbociclib tablets are indicated for the management of hormone receptor-positive breast cancer and endometrial cancer. This medication is particularly effective in cancers responsive to hormonal therapies. Additionally, it may be prescribed to address decreased appetite and unintentional weight loss associated with advanced cancers or HIV infection. Dosage and duration of Palbociclib therapy should be determined and monitored by your physician. Administration with or without food is acceptable, but consistent timing is recommended. Continue treatment as directed by your healthcare provider. Commonly reported adverse effects include increased appetite and weight, dyspnea, vasomotor flushes (facial and neck warmth), hypertension, and constipation. Many of these effects are transient and resolve with continued treatment. Report any persistent or bothersome side effects to your doctor; management strategies may be available. Complete disclosure of all medications currently being used is crucial, as interactions may diminish Palbociclib's efficacy or alter its effects. This medication is contraindicated during pregnancy and lactation. Regular blood tests to assess hormone and glucose levels are usually recommended during treatment.

Uses of Cravihenz Tablet

Cancers of the breast and uterine lining

Major Benefits of Cravihenz Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cravihenz Tablet can be administered with or without food, though consistent timing is recommended.

Common Side effects of Cravihenz Tablet:

  • Increased appetite
  • Weight gain
  • Hot flashes
  • High blood pressure
  • Constipation

How to use Cravihenz Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cravihenz Tablet can be consumed with or without food, though consistent timing is recommended.

How Cravihenz Tablet works:

Cravihenz tablets contain a progestin, a type of female hormone. This medication modifies hormone levels in women with breast or endometrial cancer, thereby hindering cancer cell proliferation. A common side effect is weight gain, often attributed to increased appetite.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Cravihenz Tablet may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Use of Cravihenz Tablet is strongly contraindicated during pregnancy. Pregnant women should consult their physician; research in both animal and human studies has revealed substantial risks to fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Cravihenz Tablet while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Cravihenz Tablet.

KidneyKidneyCAUTION

Patients with severe renal impairment should exercise caution when using Cravihenz tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should use Cravihenz Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Cravihenz Tablet :

NA

Facts to Know About Cravihenz Tablet

LabelValue
Chemical Type Progestins
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Cravihenz Tablet

Cravihenz tablets contain megestrol, a progesterone-like hormone. This medication treats hormone-sensitive breast and endometrial cancers. It's also used to increase appetite and weight in individuals with AIDS.
Cravihenz Tablets can cause weight gain, a frequent side effect, potentially from increased appetite leading to higher fat and body mass. Consult your doctor about significant weight gain. This medication treats malnutrition, appetite loss, and severe weight loss in AIDS patients, but isn't for preventing weight loss.
Take Cravihenz Tablet as directed by your doctor. It can be taken anytime, with or without food, but consistency (e.g., at the same time daily) aids in remembering your dose. Swallow the tablet whole with water. If unsure, consult your physician.
Cravihenz Tablets don't stop menstruation, but can disrupt your menstrual cycle, potentially causing breakthrough bleeding. This limits its use in women with HIV. Consult your doctor if breakthrough bleeding occurs during treatment.
Cravihenz tablets aren't chemotherapy; they're a synthetic progesterone hormone. They're used to treat breast and endometrial (uterine) cancers by altering hormones that fuel cancer growth.
Don't take Cravihenz if you're pregnant or planning to become pregnant. If you conceive while taking it, contact your doctor immediately, as Cravihenz may harm your unborn child, potentially causing sex organ abnormalities in male and female babies if taken during the first trimester. Your doctor will likely recommend a pregnancy test before starting treatment.
Cravihenz Tablets do not prevent pregnancy. While they may alter your menstrual cycle, they offer no contraceptive protection. Therefore, use a reliable birth control method. Consult your doctor if you have any questions or concerns.
Cravihenz tablets contain megestrol acetate, a synthetic progesterone. This medication treats hormone-sensitive breast and endometrial cancers. It's also used to stimulate appetite and weight gain in individuals with AIDS.
Cravihenz Tablets do not require refrigeration. Store below 25°C in the original packaging to protect from moisture.
Cravihenz Tablets are not approved for treating hot flashes. Consult your doctor before using them. Estrogen (women) and androgen (men) are typically used, but are unsuitable for those with breast or prostate cancer, respectively.
Cravihenz Tablet
346
MRP 400
13% off